SEC Form D · filed April 9, 2025
Invea Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Demetrios J. Kydonieus · Guilford, CTDirectorShunichiro "Steve" J. Okada · Guilford, CTExecStephen J. Doberstein · Guilford, CTDirectorKerrie J. Brady · Guilford, CTDirectorJonathan J. Zalevsky · Guilford, CTDirectorMichael J. Aiello · Guilford, CTExecAman Kant · Guilford, CTExecKrishnan Nandabalan · Guilford, CTExec · DirectorSalvatore J. Alesci · Guilford, CTExecKerrie J. Brady · Guilford, CTDirectorStephen J. Doberstein · Guilford, CTDirectorMichael J. Aiello · Guilford, CTExecAman Kant · Guilford, CTExecSalvatore J. Alesci · Guilford, CTExecDemetrios J. Kydonieus · Guilford, CTDirectorShunichiro "Steve" J. Okada · Guilford, CTExecKrishnan Nandabalan · Guilford, CTExec · DirectorJonathan J. Zalevsky · Guilford, CTDirectorPeter Cheesbrough · Vancouver, British Columbia, CanadaExec · DirectorLawrence Page · Vancouver, British Columbia, CanadaExecRussell Ball · Vancouver, British Columbia, CanadaDirectorArie Page · Vancouver, British Columbia, CanadaDirectorPaul Grossinger · Burlington, WAExecMatthew Faulkner · Denver, CODirectorCyrus Gentry · Denver, CODirectorRandall D. Ginn · Bellevue, WAExecEdward Casserley · Denver, COExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗